Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Ganoderma lucidum extract may help treat stress-related hair loss.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Lowering testosterone speeds up wound healing in male mice.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Chromosomal differences affect how muscle cells respond to testosterone.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.